These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33129010)

  • 41. Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Weibing L; Kuwabara S
    J Neurol Sci; 2017 Aug; 379():18-21. PubMed ID: 28716237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activities of Daily Living and Their Relationship to Health-Related Quality of Life in Patients with Parkinson Disease After Subthalamic Nucleus Deep Brain Stimulation.
    Gorecka-Mazur A; Furgala A; Krygowska-Wajs A; Pietraszko W; Kwinta B; Gil K
    World Neurosurg; 2019 May; 125():e552-e562. PubMed ID: 30716489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apathy in Parkinson's disease with REM sleep behavior disorder.
    Bargiotas P; Ntafouli M; Lachenmayer ML; Krack P; Schüpbach WMM; Bassetti CLA
    J Neurol Sci; 2019 Apr; 399():194-198. PubMed ID: 30826716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson's disease.
    Pellaprat J; Ory-Magne F; Canivet C; Simonetta-Moreau M; Lotterie JA; Radji F; Arbus C; Gerdelat A; Chaynes P; Brefel-Courbon C
    Parkinsonism Relat Disord; 2014 Jun; 20(6):662-4. PubMed ID: 24685343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001.
    Constantinescu R; Eriksson B; Jansson Y; Johnels B; Holmberg B; Gudmundsdottir T; Renck A; Berglund P; Bergquist F
    Clin Neurol Neurosurg; 2017 Mar; 154():43-48. PubMed ID: 28113102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bilateral subthalamic nucleus stimulation improves health-related quality of life in Parkinsonian patients.
    Erola T; Karinen P; Heikkinen E; Tuominen J; Haapaniemi T; Koivukangas J; Myllylä V
    Parkinsonism Relat Disord; 2005 Mar; 11(2):89-94. PubMed ID: 15734666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sleep parameters associated with long-term outcome following subthalamic deep brain stimulation in Parkinson's disease.
    Torun NA; Senel GB; Gunduz A; Karadeniz D; Kiziltan G; Ertan S; Aydin S; Yagci S; Apaydin H
    Rev Neurol (Paris); 2020 May; 176(4):277-284. PubMed ID: 31521396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.
    Kim HJ; Jeon BS; Paek SH; Lee KM; Kim JY; Lee JY; Kim HJ; Yun JY; Kim YE; Yang HJ; Ehm G
    J Neurol; 2014 Jun; 261(6):1090-6. PubMed ID: 24687897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A quantitative analysis of the effect of bilateral subthalamic nucleus-deep brain stimulation on subjective and objective sleep parameters in Parkinson's disease.
    Yin Z; Bai Y; Guan B; Jiang Y; Wang Z; Meng F; Yang A; Zhang J
    Sleep Med; 2021 Mar; 79():195-204. PubMed ID: 33208282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire.
    Suzuki K; Miyamoto T; Miyamoto M; Watanabe Y; Suzuki S; Tatsumoto M; Iwanami M; Sada T; Kadowaki T; Numao A; Hashimoto K; Sakuta H; Hirata K
    BMC Neurol; 2013 Feb; 13():18. PubMed ID: 23394437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease patients over 75 years of age.
    Sharma VD; Lyons KE; Nazzaro JM; Pahwa R
    J Neurol Sci; 2019 Apr; 399():57-60. PubMed ID: 30772762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy.
    Rothlind JC; York MK; Carlson K; Luo P; Marks WJ; Weaver FM; Stern M; Follett K; Reda D;
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):622-9. PubMed ID: 25185211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
    Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective, controlled study of non-motor effects of subthalamic stimulation in Parkinson's disease: results at the 36-month follow-up.
    Jost ST; Sauerbier A; Visser-Vandewalle V; Ashkan K; Silverdale M; Evans J; Loehrer PA; Rizos A; Petry-Schmelzer JN; Reker P; Fink GR; Franklin J; Samuel M; Schnitzler A; Barbe MT; Antonini A; Martinez-Martin P; Timmermann L; Ray-Chaudhuri K; Dafsari HS;
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):687-694. PubMed ID: 32371534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease?
    Rizzone MG; Fasano A; Daniele A; Zibetti M; Merola A; Rizzi L; Piano C; Piccininni C; Romito LM; Lopiano L; Albanese A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):376-81. PubMed ID: 24508574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson's disease.
    Dulski J; Schinwelski M; Konkel A; Grabowski K; Libionka W; Wąż P; Sitek EJ; Sławek J
    Parkinsonism Relat Disord; 2019 Jul; 64():138-144. PubMed ID: 30975618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.